ASRT Assertio Holdings Inc.

Assertio Holdings, Inc. to Host Investor and Business Development Meetings January 9-11, 2023 in San Francisco

Assertio Holdings, Inc. to Host Investor and Business Development Meetings January 9-11, 2023 in San Francisco

Meetings to Take Place Adjacent to JP Morgan Healthcare Conference

LAKE FOREST, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that its executive team will host one-on-one investor and business development meetings in San Francisco January 9-11, 2023. The individual meetings will take place at the same time as the annual JP Morgan Healthcare Conference.

For more information and to schedule an investor meeting, please contact Matt Kreps, investor relations for Assertio, at . To arrange a business development meeting, please contact Vanessa Fox, Vice President, Business Development and Commercial Analytics for Assertio, at .

About Assertio

Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more visit .

Investor Contact:

Matt Kreps

Managing Director

Darrow Associates

M: 214-597-8200



EN
13/12/2022

Underlying

ASRTAssertio Holdings Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Assertio Holdings Inc.

 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports Second Quarter 2025 Financial Results

Assertio Reports Second Quarter 2025 Financial Results Second Quarter Total Net Product Sales of $28.8 Million, Cash and Investments Increase to $98.2 Million Narrows Guidance on Continued Progress Implementing Long-Term Business Strategy LAKE FOREST, Ill., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the second quarter ended June 30, 2025. Said Brendan O...

August 11, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Result...

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025 LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide business updates on the Company’s 2025 strategic plans. To access the live webcast, conference call inform...

August 5, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio to Participate in the Alliance Global Partners Healthcare Com...

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025 LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025. Mr. O’Grady’s fireside chat will be webcast live at 11:20 a.m. ET. To join the event, please register at , or visit the Events & Presentations page at the Company’s investor relations websit...

May 19, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports First Quarter 2025 Financial Results

Assertio Reports First Quarter 2025 Financial Results First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Sustainable Near-Term Growth and Increased Long-Term Value LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the first quarter ende...

May 12, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025 LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial results on Monday, May 12, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and update the Company’s 2025 strategic plans. To access the live webcast, conference call information, and other materials, ...

May 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch